JCI Insight Impact Factor 2026: What Researchers Should Know

Short answer

JCI Insight impact factor is 6.1 (2024 JCR). It's the sister journal to JCI (IF 11.9), published by the American Society for Clinical Investigation. It focuses on translational and clinical research. Acceptance rate is roughly 20-25%. It's a strong option for clinical mechanistic work that doesn't meet JCI's higher bar.

Best for

• Translational research with clinical data and mechanistic depth
• Papers redirected from JCI through the transfer pathway
• Clinical immunology, metabolism, cardiovascular, and infectious disease research

Not best for

• Basic science without clinical relevance
• Work that needs the prestige of a top-10 IF journal
• Papers better suited to discipline-specific clinical journals

What JCI Insight Actually Publishes

JCI Insight launched in 2016 as a companion to the Journal of Clinical Investigation. The editorial pitch: publish high-quality translational and clinical research that's scientifically rigorous but doesn't meet JCI's threshold for redefining disease understanding.

In practice, JCI Insight publishes three main types of work:

• Translational studies with human data and mechanistic components that don't reach the novelty bar for JCI or Nature Medicine
• Clinical research with strong methodology and clear implications, including cohort studies, biomarker validation, and clinical trial ancillary analyses
• JCI redirects where the editors recognized scientific quality but felt the impact wasn't sufficient for the parent journal

The journal covers immunology, metabolism, cardiology, oncology, infectious disease, neuroscience, and other clinical research areas. It doesn't publish basic science without a translational or clinical angle.

Impact Factor Context

JCI Insight's IF of 6.1 places it in a competitive middle tier for clinical research journals. Here's how it compares:

The 5-year IF is approximately 7.8, which is a better indicator of sustained citation impact than the 2-year window. JCI Insight papers tend to accumulate citations steadily over time, reflecting the clinical research audience's longer reading and citing cycles.

The JCI Transfer Pathway

One of JCI Insight's most practical features is the transfer system from JCI. When JCI editors reject a manuscript but recognize its quality, they can offer to transfer it to JCI Insight with the existing reviewer reports. This means:

• You don't start the review process from scratch
• JCI Insight editors see the JCI reviewers' assessments, which speeds up their decision
• The transfer typically results in a faster time to first decision at JCI Insight

Not every JCI rejection comes with a transfer offer. Papers rejected for fundamental scientific problems won't be transferred. But papers rejected because the novelty wasn't sufficient for JCI's higher bar often qualify.

Acceptance Rate and Review Process

JCI Insight's acceptance rate is estimated at 20-25%. The review process typically involves 2-3 reviewers with expertise in the clinical area. Time to first decision averages 4-6 weeks for manuscripts that go to external review. Desk rejections come faster, usually within 1-2 weeks.

The journal uses a standard revision model. Most accepted papers go through at least one round of revision. Major revisions are common for papers that need additional clinical data analysis or mechanistic validation.

Who Should Target JCI Insight

JCI Insight works well for clinical researchers who have strong translational data but whose findings are incremental rather than field-defining. It's a natural landing spot for:

• Postdocs in clinical departments with human cohort data and mechanistic follow-up
• Clinical trialists with ancillary analyses that don't fit the primary trial journal
• Immunology and metabolism researchers with patient-derived data

For comparison with the parent journal, see JCI impact factor and Is JCI a good journal?. For broader journal selection guidance, see how to choose a journal and the JCI submission guide.

Sources

• Clarivate JCR 2024: JCI Insight IF 6.1, 5-year IF approximately 7.8
• ASCI journal pages for JCI and JCI Insight, accessed March 2026
• JCI Insight editorial policies on manuscript transfer